Business Description
![Kiora Pharmaceuticals Inc Kiora Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C0000APFQ.png?14)
Kiora Pharmaceuticals Inc
NAICS : 325413
SIC : 2835
ISIN : US30233M1071
Description
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 332.72 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-EBITDA | 0.04 | |||||
Interest Coverage | 519 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -1.9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 64.7 | |||||
3-Year EPS without NRI Growth Rate | 68.9 | |||||
3-Year FCF Growth Rate | 68.4 | |||||
3-Year Book Growth Rate | -77.5 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.65 | |||||
9-Day RSI | 50.32 | |||||
14-Day RSI | 48.83 | |||||
6-1 Month Momentum % | -10.92 | |||||
12-1 Month Momentum % | -25.34 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 21.02 | |||||
Quick Ratio | 21.02 | |||||
Cash Ratio | 19.63 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -281.4 | |||||
Shareholder Yield % | -156.26 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 38.93 | |||||
Net Margin % | 17.54 | |||||
FCF Margin % | 44.61 | |||||
ROE % | 19.25 | |||||
ROA % | 12.94 | |||||
ROIC % | 60.74 | |||||
ROC (Joel Greenblatt) % | 2456.86 | |||||
ROCE % | 12.64 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 2.46 | |||||
Price-to-Owner-Earnings | 6.77 | |||||
PS Ratio | 1.05 | |||||
PB Ratio | 0.36 | |||||
Price-to-Tangible-Book | 0.48 | |||||
EV-to-EBIT | -7.41 | |||||
EV-to-EBITDA | -7.28 | |||||
EV-to-Revenue | -1.16 | |||||
EV-to-Forward-Revenue | 0.66 | |||||
EV-to-FCF | -2.6 | |||||
Price-to-Net-Current-Asset-Value | 0.49 | |||||
Price-to-Net-Cash | 0.53 | |||||
Earnings Yield (Greenblatt) % | -13.5 | |||||
FCF Yield % | 56.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KPRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kiora Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 16 | ||
EPS (TTM) ($) | -14.35 | ||
Beta | -0.97 | ||
Volatility % | 47.13 | ||
14-Day RSI | 48.83 | ||
14-Day ATR ($) | 0.479216 | ||
20-Day SMA ($) | 4.3042 | ||
12-1 Month Momentum % | -25.34 | ||
52-Week Range ($) | 3.6 - 8.982 | ||
Shares Outstanding (Mil) | 2.92 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kiora Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kiora Pharmaceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Kiora Pharmaceuticals Inc Frequently Asked Questions
What is Kiora Pharmaceuticals Inc(KPRX)'s stock price today?
The current price of KPRX is $4.32. The 52 week high of KPRX is $8.98 and 52 week low is $3.60.
When is next earnings date of Kiora Pharmaceuticals Inc(KPRX)?
The next earnings date of Kiora Pharmaceuticals Inc(KPRX) is .
Does Kiora Pharmaceuticals Inc(KPRX) pay dividends? If so, how much?
Kiora Pharmaceuticals Inc(KPRX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |